Skip to main content
Premium Trial:

Request an Annual Quote

Roche NimbleGen, Affymetrix Expand Microarray IP Agreement

NEW YORK (GenomeWeb News) - Roche NimbleGen said today it has expanded a patent license agreement with Affymetrix to include diagnostic rights to array-based DNA analysis and array-based re-sequencing.
NimbleGen and Affymetrix originally agreed to the patent license, which gave NimbleGen the rights to patents related to the manufacture, use, and sale of nucleic acid microarrays, in October 2006. 
When Roche purchased NimbleGen last June for $272 million, the licensing rights were transferred to Roche NimbleGen.
Roche NimbleGen makes high-density arrays of long oligo probes used in studying genomic and epigenomics variation.
Financial terms of the latest agreement were not released.
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.